GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Influencers see UPI MDR introduction in India as vital step for ecosystem monetization, reveals GlobalData

The introduction of a 0.4% Merchant Discount Rate (MDR) on Person-to-Merchant (P2M) Unified Payments Interface (UPI) transactions above INR 2,000 ($20.8) has sparked substantial debate among influencers on X. Influencers see the measure as an attempt to create a durable revenue base for banks, acquirers, and payment platforms, but they also expect merchants to test […]
Read more

Physical AI to redefine the future of robotics, says GlobalData

Physical AI marks a shift from machines that follow fixed instructions to embodied systems that perceive, reason, and act autonomously. It can be deployed in robots, autonomous vehicles, drones, and industrial systems. Commercialization began in 2026 across industries ranging from discrete manufacturing and healthcare to mining, energy, and transportation. It will accelerate from 2027 as […]
Read more

Slackforce Surfaces strengthens Slackbot’s role as an AI-powered enterprise interface, says GlobalData

Slackforce Surfaces marks a significant advance in AI-enabled enterprise collaboration, turning Slackbot into a practical interface for live business data and context. By automatically creating and refreshing dashboards, reports, presentations, and other views, the capability can reduce the friction of gathering information while helping users derive deeper insights and make faster, more informed decisions, says […]
Read more

AI emerges as growing competitive threat to UK commercial brokers, reveals GlobalData

UK commercial brokers are increasingly recognizing artificial intelligence (AI) as a competitive threat, as conversational AI creates new ways for customers to research insurance and obtain pricing without initially engaging a broker, according to a survey by GlobalData, a leading intelligence and productivity platform.  GlobalData’s 2026 UK Commercial Broker Survey* found that 9.2% of brokers […]
Read more

Classical Hodgkin lymphoma diagnosed incident cases to reach 28,000 across 8MM in 2035, forecasts GlobalData

The burden of diagnosed incident cases of classical Hodgkin lymphoma in the 8MM* is forecast to increase at an annual growth rate (AGR) of 0.31%, from 27,000 in 2025 to 28,000 cases in 2035, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Hodgkin Lymphoma: Epidemiology Report and Forecast,” reveals that the […]
Read more

Lunsekimig results bolster Sanofi’s strategy to defend respiratory franchise ahead of Dupixent patent expiry, says GlobalData

Lunsekimig’s Phase IIb asthma data strengthen its case as a differentiated next-generation biologic, with dose-dependent reductions in exacerbations and improvements in lung function supporting progression into Phase III. The results could sharpen Sanofi’s strategy to defend its respiratory franchise ahead of Dupixent’s patent expiry, while intensifying competition in an increasingly crowded asthma biologics market, says […]
Read more

Tozorakimab results broaden biologic treatment across COPD population, says GlobalData

Tozorakimab’s (interleukin-33 (IL-33) inhibitor) Phase III chronic obstructive pulmonary disease (COPD) results strengthen the case for a new class of biologic treatment that could extend beyond eosinophil-defined patients. Consistent efficacy across OBERON and TITANIA trials, including those with low eosinophil counts, could broaden the addressable COPD population and intensify competition in a market where current […]
Read more

Autoliv’s Toyota onboarding for HBM suite highlights race to industrialize virtual crash testing, says GlobalData

Virtual safety engineering is moving from a research and development (R&D) adjunct to a core pillar of vehicle development as automakers face shorter product cycles, stricter consumer-safety expectations, and rising complexity from electrification and advanced driver-assistance systems (ADAS). Against this backdrop, Autoliv onboarding Toyota as the first customer to assess its Human Body Model (HBM) […]
Read more

Vodafone TV will boost VodafoneThree’s UK fixed-mobile multiplay push but needs sharper differentiation, says GlobalData

Vodafone TV’s October 2026 launch will strengthen VodafoneThree’s UK fixed-mobile convergence strategy by filling a key pay-TV gap and extending TV access to mobile-only customers. The move could accelerate multiplay adoption and support 5G+ and broadband cross-selling, but the British telco needs stronger operator-specific benefits and bundled incentives to establish a compelling proposition in an […]
Read more

Americas to lead global microgrids market growth through 2030, forecasts GlobalData

The global microgrids market is poised for strong growth as governments, utilities, commercial facilities, military bases, and remote communities increase investment in resilient, decentralized, and digitally managed power systems. Rising grid reliability concerns, extreme weather events, renewable energy integration, and the need for a secure and reliable power supply are accelerating microgrid deployment across critical […]
Read more

Mobileye Drive’s permit share in Germany points to more regulated, fleet-led path for Level 4 autonomy, says GlobalData

The autonomous vehicle (AV) market is increasingly bifurcated: most near-term revenues are coming from advanced driver assistance and limited “supervised” automation in consumer cars, while Level 4 progress is being concentrated in geofenced pilots for shuttles, ride-pooling, and goods movement where regulators can tightly define operating conditions. Against this backdrop, Mobileye Drive’s significant share of […]
Read more

Influencers see Apple’s latest iPhone launch as strategic pricing reset to lift premium mix, reveals GlobalData

Apple’s latest product launch during the recent “Surprise and Shine” event sparked strong reactions from influencers on X. While the iPhone Duo’s price drew immediate attention, influencers also pointed to Apple’s simultaneous price increases across older and mainstream iPhone models as evidence that the company is resetting the pricing structure of its wider portfolio. Many […]
Read more

PPPs reshape Gulf infrastructure delivery as governments expand private-sector participation, says MEED, a GlobalData company

Dubai, UAE — 11September 2026: Public-private partnerships (PPPs) are becoming an important mechanism for infrastructure delivery across the Middle East and North Africa, with the Gulf Cooperation Council (GCC) leading the shift as governments diversify their economies and expand private-sector participation, reveals MEED, the Middle East-focused business intelligence platform of GlobalData Plc. The growth of […]
Read more

Mabwell’s 9MW1911 data support further testing of ST2 blockade in COPD, says GlobalData

At the European Respiratory Society (ERS) Congress 2026, Mabwell and collaborating investigators presented results from the company’s Phase Ib/IIa study in patients with chronic obstructive pulmonary disease (COPD). The randomized, double-blind, placebo-controlled trial evaluated the therapeutic efficacy and safety of 9MW1911, an anti-ST2 monoclonal antibody, in moderate-to-severe COPD. Although the efficacy findings were exploratory and […]
Read more

Apple intends to mainstream foldable smartphones using its installed base and brand power, says GlobalData

Following the news that Apple unveiled its first foldable smartphone, the iPhone Duo, amid a flurry of product announcements at its annual September showcase; Amanda Mitchell, Senior Analyst – Telecoms Practice, Technology at GlobalData, a leading intelligence and productivity platform, offers her view: “The move signals Apple’s intent to put its brand gravity and installed base […]
Read more

China’s rise as a biopharma innovation hub reshapes global dealmaking strategies, says GlobalData

China’s biopharma ecosystem is reshaping how global pharmaceutical companies source innovation, build pipelines and structure deals. As Chinese-origin assets gain global validation and licensing values rise, China is becoming an increasingly strategic component of international growth strategies while regulatory and geopolitical complexity raises the stakes for companies deciding how deeply to engage, says GlobalData Healthcare, […]
Read more

ERS 2026 data positions Infex’s RESP-X at forefront of Pa-colonized NCFB space, says GlobalData

At the 2026 European Respiratory Society (ERS) International Congress, Infex Therapeutics presented a new analysis of Phase IIa results for RESP-X (INFEX702) in P. aeruginosa (Pa)-colonized non-cystic fibrosis bronchiectasis (NCFB). This matters because, despite the 2025 approval of Insmed’s Brinsupri (brensocatib) as the first therapy for NCFB, no approved treatment yet targets Pa, the disease’s […]
Read more
1 2 3 778